Single-nucleotide polymorphisms in the p53 pathway.
暂无分享,去创建一个
A. Levine | H. Robins | S. Harris | E. Bond | G. Bond | Z. Feng | K. Hirshfield | G. Gil | A. K. Teresky | W. Hu | X. Yu | X. Yu
[1] Rebecca A. Ihrie,et al. Perp Is a p63-Regulated Gene Essential for Epithelial Integrity , 2005, Cell.
[2] Geoffrey B. Nilsen,et al. Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.
[3] A. Merlo,et al. Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation* , 2004, Journal of Biological Chemistry.
[4] J. Testa,et al. A Portrait of AKT Kinases: Human Cancer and Animal Models Depict a Family with Strong Individualities , 2004, Cancer biology & therapy.
[5] Rebecca A. Ihrie,et al. Perp-etrating p53-Dependent Apoptosis , 2004, Cell cycle.
[6] M. Karayiorgou,et al. Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.
[7] Rebecca A. Ihrie,et al. Perp Is a Mediator of p53-Dependent Apoptosis in Diverse Cell Types , 2003, Current Biology.
[8] Shih-Jen Hwang,et al. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. , 2003, American journal of human genetics.
[9] R. Eeles,et al. Apoptosis, ageing and cancer susceptibility , 2003, British Journal of Cancer.
[10] M. Murphy,et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential , 2003, Nature Genetics.
[11] Toshiyuki Obata,et al. Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53* , 2002, The Journal of Biological Chemistry.
[12] Moshe Oren,et al. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis , 2002, Oncogene.
[13] A. Levine,et al. The p53 functional circuit. , 2001, Journal of cell science.
[14] Thierry Soussi,et al. Assessing TP53 status in human tumours to evaluate clinical outcome , 2001, Nature Reviews Cancer.
[15] Yong Liao,et al. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation , 2001, Nature Cell Biology.
[16] L. Mayo,et al. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] E. Appella,et al. Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.
[18] Timothy B. Stockwell,et al. The Sequence of the Human Genome , 2001, Science.
[19] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[20] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[21] R. Camplejohn,et al. p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours , 2001, Cell proliferation.
[22] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[23] B. Gusterson,et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour , 2000, Nature Genetics.
[24] S. Lowe,et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. , 2000, Genes & development.
[25] R. Eeles,et al. The value of rapid functional assays of germline p53 status in LFS and LFL families , 2000, British Journal of Cancer.
[26] L. Donehower,et al. Effects of genetic background on tumorigenesis in p53‐deficient mice , 1995, Molecular carcinogenesis.
[27] R. Birgander,et al. Is p53 polymorphism maintained by natural selection? , 1994, Human heredity.
[28] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[29] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[30] F. Li,et al. Familial cancer syndromes and clusters. , 1990, Current problems in cancer.
[31] M. Hammerschmidt,et al. Perp is required for tissue-specific cell survival during zebrafish development , 2005, Cell Death and Differentiation.